Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
22.07
-0.72 (-3.16%)
Dec 5, 2025, 4:00 PM EST - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Astrana Health stock have an average target of 43, with a low estimate of 26 and a high estimate of 56. The average target predicts an increase of 94.83% from the current stock price of 22.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $44 → $37 | Strong Buy | Maintains | $44 → $37 | +67.65% | Nov 25, 2025 |
| Barclays | Barclays | Hold Maintains $36 → $26 | Hold | Maintains | $36 → $26 | +17.81% | Nov 24, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $40 → $35 | Strong Buy | Maintains | $40 → $35 | +58.59% | Nov 10, 2025 |
| BTIG | BTIG | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +103.90% | Nov 7, 2025 |
| Barclays | Barclays | Hold Initiates $36 | Hold | Initiates | $36 | +63.12% | Apr 1, 2025 |
Financial Forecast
Revenue This Year
3.22B
from 2.03B
Increased by 58.37%
Revenue Next Year
4.04B
from 3.22B
Increased by 25.48%
EPS This Year
0.60
from 0.90
Decreased by -33.25%
EPS Next Year
1.38
from 0.60
Increased by 129.03%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.3B | 4.4B | ||||
| Avg | 3.2B | 4.0B | ||||
| Low | 3.1B | 3.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 63.6% | 36.8% | ||||
| Avg | 58.4% | 25.5% | ||||
| Low | 51.0% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.30 | 2.23 | |
| Avg | 0.60 | 1.38 | |
| Low | 0.35 | 0.03 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 44.7% | 270.5% | |
| Avg | -33.2% | 129.0% | |
| Low | -60.8% | -95.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.